Terms: = Breast cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
314 results:
1. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-met in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
2. c-met-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J; Chang ES; Kim JY; Chelakkot C; Sung M; Song JY; Jung K; Lee JH; Choi JY; Kim NY; Lee H; Kang MR; Kwon MJ; Shin YK; Park YH; Choi YL
Breast Cancer Res; 2024 Jan; 26(1):13. PubMed ID: 38238761
[TBL] [Abstract] [Full Text] [Related]
3. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
4. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract] [Full Text] [Related]
5. Clinical, histological features, and predictors of relapse in patients with idiopathic granulomatous mastitis.
Abbi B; Sanghavi N; Lanjewar S; Fineberg S; Xie X; Gupta A; Kumthekar A; Ayesha B
Medicine (Baltimore); 2023 Nov; 102(44):e35679. PubMed ID: 37933043
[TBL] [Abstract] [Full Text] [Related]
6. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract] [Full Text] [Related]
7. BRCA1 and BRCA2 mutations and their clinical relevance in selected women diagnosed with triple-negative breast cancer in Kenya: a descriptive cross-sectional study.
Rioki JN; Muchiri L; Mweu M; Nyagol J; Songok E; Mwangi J; Oyaro M; Ong'ang'o LB; Rogena E
Pan Afr Med J; 2023; 45():102. PubMed ID: 37719058
[TBL] [Abstract] [Full Text] [Related]
8. Adverse Crosstalk between Extracellular Matrix Remodeling and Ferroptosis in Basal breast cancer.
Desterke C; Cosialls E; Xiang Y; Elhage R; Duruel C; Chang Y; Hamaï A
Cells; 2023 Aug; 12(17):. PubMed ID: 37681908
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and clinicopathological role of RACK1 for cancer patients: a systematic review and meta-analysis.
Wang Q; Jiang S; Wu Y; Zhang Y; Huang M; Qiu Y; Luo X
PeerJ; 2023; 11():e15873. PubMed ID: 37601269
[TBL] [Abstract] [Full Text] [Related]
10. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
[TBL] [Abstract] [Full Text] [Related]
11. The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer.
Chen C; Wang R; Wang B; Wu Y; Jiang J
PLoS One; 2023; 18(8):e0288078. PubMed ID: 37535561
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Preoperative Nutritional Assessment on Other-Cause Survival after Gastrectomy in Patients with Gastric cancer.
Matsui R; Inaki N; Tsuji T
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513603
[TBL] [Abstract] [Full Text] [Related]
13. Influence of Prognostic Nutritional Index on the Surveillance After Surgery-Based Systematic Therapy for breast cancer.
Zhang X; Liu Y; Mu D
Am Surg; 2023 Dec; 89(12):6157-6171. PubMed ID: 37488662
[TBL] [Abstract] [Full Text] [Related]
14. Improving quality of life and symptom experience in patients with metastatic breast cancer: A systematic review of supportive care interventions.
Keane D; Phillips G; Mitchell N; Connolly RM; Hegarty J
Psychooncology; 2023 Aug; 32(8):1192-1207. PubMed ID: 37434307
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological characteristics of Non-Small Cell Lung cancer (NSCLC) patients with c-met exon 14 skipping mutation, met overexpression and amplification.
Ding C; Qiu Y; Zhang J; Wei W; Gao H; Yuan Y; Wang X
BMC Pulm Med; 2023 Jul; 23(1):240. PubMed ID: 37400762
[TBL] [Abstract] [Full Text] [Related]
16. Amounts of tissue magnesium and some trace elements in cats with mammary tumors related to various clinicopathological parameters.
Günay Uçmak Z; Koenhemsi L; Ateş F; Tarhan D; Öztürk Gürgen H; Yildirim F; Uçmak M; Kirşan İ; Ercan AM; Or ME
J Trace Elem Med Biol; 2023 Sep; 79():127246. PubMed ID: 37393772
[TBL] [Abstract] [Full Text] [Related]
17. Surgery on metastatic Foci is a Better Strategy for Stage IV breast cancer Patients with only Nonregional Lymph Node metastasis.
Jiao Y; Guo X; Wu H; Lv Q
Adv Ther; 2023 Jul; 40(7):3247-3262. PubMed ID: 37270436
[TBL] [Abstract] [Full Text] [Related]
18. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang ML; Jurczak W; Zinzani PL; Eyre TA; Cheah CY; Ujjani CS; Koh Y; Izutsu K; Gerson JN; Flinn I; Tessoulin B; Alencar AJ; Ma S; Lewis D; Lech-Maranda E; Rhodes J; Patel K; Maddocks K; Lamanna N; Wang Y; Tam CS; Munir T; Nagai H; Hernandez-Ilizaliturri F; Kumar A; Fenske TS; Seymour JF; Zelenetz AD; Nair B; Tsai DE; Balbas M; Walgren RA; Abada P; Wang C; Zhao J; Mato AR; Shah NN
J Clin Oncol; 2023 Aug; 41(24):3988-3997. PubMed ID: 37192437
[TBL] [Abstract] [Full Text] [Related]
19. Less necessity of adjuvant S-1 treatment in non-monarchE-eligible patients.
Yu M; Takada M; Yamada H; Fujimoto H; Sakakibara J; Yamamoto H; Nagashima T; Ohtsuka M
Cancer Med; 2023 Jun; 12(12):13193-13203. PubMed ID: 37162105
[TBL] [Abstract] [Full Text] [Related]
20. Adjuvant treatment decisions among adults aged 65 years and older with early-stage hormone receptor positive breast cancer seen in a simple multidisciplinary clinic versus standard consultation.
English K; Alcorn SR; Tran HT; Smith KL; Wilkinson M; Hirose KT; O'Donnell M; Croog V; Wright JL
J Geriatr Oncol; 2023 May; 14(4):101503. PubMed ID: 37126898
[TBL] [Abstract] [Full Text] [Related]
[Next]
